학술논문
Subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma: Part 2 of the open-label, multicenter, dose-escalation phase 1b study (PAVO)
Document Type
Artikel
Author
Source
Haematologica. 106(6):1725-1732
Subject
Language
English
English
English
ISSN
1592-8721